GONÇALO ABECASIS, PH.D.

VP & Chief Genomics and Data Science Officer

Regeneron

AMY ABERNETHY, M.D., PH.D.

Former Principal Deputy Commissioner

FDA

MANUEL ASCANO, PH.D.

Associate Professor of Biochemistry

Vanderbilt University School of Medicine

Lori Aschenbrenner, Ph.D.

Director, Drug Development and Regulatory Strategy, Early Phase Development Solutions

Labcorp

JAMIL BEG

Partner

SV Health Investors

JORY BELL

General Partner

Playground Global

Andrew Bellinger, M.D., Ph.D.

Advisor

Verve Therapeutics

Gwendolyn Binder, Ph.D.

President, Science & Technology

Cabaletta Bio

MELISSA BONNER, PH.D.

Chief Scientific Officer

Nvelop Therapeutics

LUCIANA BORIO, M.D.

Venture Partner

Arch Venture Partners

DANIEL BURKHARDT, PH.D.

Manager of Strategic Scientific Projects

Cellarity

Ellen Cahir-McFarland, Ph.D.

Chief Scientific Officer

Abata Therapeutics

ROBERT CARNAHAN, PH.D.

Professor of Pediatrics, Assoc. Dir. Vanderbilt Vaccine Center

Vanderbilt University Medical Center

Caroline Chung, M.D.

VP, Chief Data Officer & Assoc Prof Radiation Oncology & Radiology

MD Anderson Cancer Center

Nancy Cox, Ph.D.

Professor of Medicine

Vanderbilt University Medical Center

Aaron Esser-Kahn, Ph.D.

Professor of Molecular Engineering

University of Chicago

Stacy Feld

Regional Head

J&J Innovation

Stephen Fesik, Ph.D.

Orrin H. Ingram II Chair in Cancer Research & Professor of Biochemistry, Pharmacology, and Chemistry

Vanderbilt University

ZANDY FORBES, PH.D.

President & CEO

MeiraGTx

Aaron Foster, Ph.D.

Chief Scientific Officer

Outpace Bio

KEVIN FRIEDMAN, PH.D.

Co-founder & CEO

Kelonia Therapeutics

Mark Frolich, M.D.

CEO

Indapta Therapeutics

CHRIS GARABEDIAN

CEO

Xontogeny

ANDREI GEORGESCU, PH.D.

Co-founder & CEO

Vivodyne

DAVID GOLDSTEIN, PH.D.

Co-founder & CEO

Actio Biosciences

JANE GROGAN, PH.D.

EVP, Head of Research

Biogen

ANIKA GUPTA, PH.D.

Principal

GV

KRISTIN HEGE, M.D.

Board Member

Mersana, Adaptimmune and Kelonia

COLIN HILL

CEO

Aitia

CHRIS HOLLOWOOD, PH.D.

CEO

Syncona

SASHA HUHALOV, PH.D.

Head of Search and Evaluation, Center for External Innovation

Takeda  Pharmaceutical

Reagan Jarvis Ph.D.

Co-Founder and CEO

Annoca AB

Carrie Jones, Ph.D.

Associate Professor of Pharmacology

Vanderbilt University

Aniket Kaloti, MBBS (M.D.), Ph.D.

Senior Managing Director, Healthcare M&A

Leerink Partners

Chaitan Khosla, Ph.D.

Professor of Chemistry

Stanford University

ERIN KIMBREL, PH.D.

President & Head of Astellas Institute for Regenerative Medicine

Astellas Pharma

SOPHIE KORNOWSKI, PHARM.D.

CEO

Boston Pharmaceuticals

John Kuriyan, Ph.D.

Dean of Basic Sciences and Professor of Biochemistry

Vanderbilt University School of Medicine

Guru Laxmikanthan, Ph.D.

Patent Attorney

Nutter

JOHN LEPORE, M.D.

CEO

ProFound Therapeutics

PATRICK LYDEN, M.D.

Professor

Keck School of Medicine of USC

Charmaine Lykins

Commercial Strategy Advisor and Former CCO

MapLight Therapeutics Inc.

SAMUEL LYNCH

Chairman & CEO, Lynch Regenerative Medicine, and Board Director,

Vanderbilt University Medical Center

MARINNA MADRID, PH.D.

Co-founder & CEO

Cellino Biotech

MATHAI MAMMEN, M.D., PH.D.

Chairman & CEO

FogPharma

Andrew Marshall, Ph.D.

Venture Partner

Scion Life Sciences

FIONA MARSHALL, PH.D.

President of Biomedical Research

Novartis

CLARE MURRAY, PH.D.

SVP Corporate Development & Operations

Life Edit Therapeutics

GREGORY NEWBY, PH.D.

Assistant Professor

Johns Hopkins University

CARL NOVINA, M.D., PH.D.

Professor

Dana-Farber Cancer Institute

STEPHANIE OESTREICH, PH.D.

Managing Director

Myeloma Investment Fund

DEBORAH PALESTRANT, PH.D.

Partner, 5AM Ventures, Exec. Chair

4:59 Initiative

Art Pappas

Managing Partner

Pappas Capital

Ania Payne, Ph.D.

Founder

Biohub Nash

Becky Pferdehirt, Ph.D.

Investment Partner

Andreessen Horowitz

Jim Ray, Ph.D.

Executive Director, Neurodegenerative Consortium

MD Anderson Cancer Center

DANIEL REICH, M.D., PH.D.

Chief, Translational Neuroradiology Section, NINDS, NIH Attending Neuroradiologist

NIH Clinical Center

JILL RICHARDSON, PH.D.

Executive Director, Neuroscience

MSD

DAN RODEN, M.D.

SVP Personalized Medicine

Vanderbilt University Medical Center

LEXI ROVNER, PH.D.

Co-founder & CEO

64x Bio

KRISHNENDU ROY, PH.D.

Dean of Engineering and Founding Director, NSF ERC for Cell Manufacturing Technologies

Vanderbilt University

JOEL SANDLER, PH.D.

Associate Partner, Healthcare Advisory

Ipsos Healthcare Advisory

Marissa Saunders, Ph.D.

Senior Director of Data Science

Recursion

ADAM SAVITZ, M.D., PH.D.

Chief Medical Officer

Alto Neuroscience

Florencia Segal, M.D.

Partner

MPM BioImpact

EVONNE SEPSIS

Managing Director

ESC Advisors

Henning Stennicke, Ph.D.

Chief Scientific Officer

Spur Therapeutics

ELIZABETH ANN STRINGER, PH.D.

Chief Scientific Officer

Nashville Biosciences

PAUL PETER TAK, M.D., PH.D.

President & CEO

Candel Therapeutics

Jérôme Van Biervliet, Ph.D.

Managing Director

VIB

GREGORY VERDINE, PH.D.

Co-Founder, President & CEO, LifeMine Therapeutics, and Professor of Chemistry

Harvard University

DANIEL VON BORNSTÄDT, M.D.

Associate Partner

McKinsey & Company

NIKHIL WAGLE, M.D.

VP & Global Head of Translational Medicine

Genentech

Wei-Qi Wei, M.D., Ph.D.

Associate Professor, Department of Biomedical Informatics, 

Vanderbilt University Medical Center

DOUGLAS WILLIAMS, PH.D.

Chairman

AC Immune

Matthew Wilson. M.D., Ph.D

Professor of Medicine

Vanderbilt University Medical Center

PETER WRIGHT, PH.D

Partner

McKinsey & Company

Asish Xavier, Ph.D.

VP, Venture Investments

JJDC/Johnson & Johnson Innovation

GUANG YANG, PH.D.

Partner

McKinsey & Company

Dan Zhang, M.D.

Co-Chairman

Hillgene

CAROLYNE ZIMMERMANN

Chief Business Officer

SonoThera